For the 2019 performance year, eligible clinicians will receive a Cost performance category score that accounts for 15% of their final MIPS score.
ECs do not need to attest to anything for this component. CMS will calculate this score by reviewing claims data for MIPS ECs. In 2019, CMS will analyze the following Cost measures:
- Medicare spending per beneficiary (MSPB)
- Total per capita cost
- Elective outpatient percutaneous coronary intervention (PCI) (Procedural)
- Knee arthroplasty (Procedural)
- Revascularization for lower extremity chronic critical limb ischemia (Procedural)
- Routine cataract removal with intraocular lens (IOL) implantation (Procedural)
- Screening/surveillance colonoscopy (Procedural)
- Intracranial hemorrhage or cerebral infarction (Acute inpatient medical condition)
- Simple pneumonia with hospitalization (Acute inpatient medical condition)
- ST-Elevation myocardial infarction (STEMI) with percutaneous coronary intervention (PCI) (Acute inpatient medical condition)
ASA continues to advocate for physician anesthesiologists to be fairly and accurately assessed under the MIPS cost component.
ASA expects to release more information on the 2019 MIPS Cost Component. For information on the 2017 and 2018 QPP, visit the QPP Resource Library and search by performance year.
More MIPS Components
You can also find CMS Resources here and ASA FAQs here for all things MACRA.